OKDAV Stock Overview
Provides healthcare and wellbeing products primarily in Sweden and Finland. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Oriola Oyj Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.91 |
52 Week High | €1.23 |
52 Week Low | €0.89 |
Beta | 0.61 |
1 Month Change | -1.09% |
3 Month Change | -7.71% |
1 Year Change | -18.75% |
3 Year Change | -54.16% |
5 Year Change | -56.25% |
Change since IPO | -53.81% |
Recent News & Updates
Recent updates
Shareholder Returns
OKDAV | FI Healthcare | FI Market | |
---|---|---|---|
7D | 1.1% | 1.1% | 1.6% |
1Y | -18.8% | 3.3% | -6.9% |
Return vs Industry: OKDAV underperformed the Finnish Healthcare industry which returned 2.2% over the past year.
Return vs Market: OKDAV underperformed the Finnish Market which returned -8.7% over the past year.
Price Volatility
OKDAV volatility | |
---|---|
OKDAV Average Weekly Movement | 2.0% |
Healthcare Industry Average Movement | 4.3% |
Market Average Movement | 4.3% |
10% most volatile stocks in FI Market | 7.8% |
10% least volatile stocks in FI Market | 2.8% |
Stable Share Price: OKDAV has not had significant price volatility in the past 3 months compared to the Finnish market.
Volatility Over Time: OKDAV's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 804 | Katarina Gabrielson | oriola.com |
Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. In addition, it provides pharmaceutical logistics and dose dispensing services.
Oriola Oyj Fundamentals Summary
OKDAV fundamental statistics | |
---|---|
Market cap | €163.17m |
Earnings (TTM) | -€5.10m |
Revenue (TTM) | €1.63b |
0.1x
P/S Ratio-31.8x
P/E RatioIs OKDAV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
OKDAV income statement (TTM) | |
---|---|
Revenue | €1.63b |
Cost of Revenue | €1.47b |
Gross Profit | €159.30m |
Other Expenses | €164.40m |
Earnings | -€5.10m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 04, 2025
Earnings per share (EPS) | -0.028 |
Gross Margin | 9.79% |
Net Profit Margin | -0.31% |
Debt/Equity Ratio | 45.9% |
How did OKDAV perform over the long term?
See historical performance and comparisonDividends
7.8%
Current Dividend Yield-249%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/27 07:58 |
End of Day Share Price | 2024/12/27 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Oriola Oyj is covered by 15 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Morten Larsen | ABG Sundal Collier |
Iiris Theman | Carnegie Investment Bank AB |
Panu Laitinmäki | Danske Bank |